Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach

被引：17

作者：

Matsufuji, Tetsuyoshi ^{[1
]}

Shimada, Kousei ^{[1
]}

Kobayashi, Shozo ^{[1
]}

Ichikawa, Masanori ^{[1
]}

Kawamura, Asuka ^{[1
]}

Fujimoto, Teppei ^{[1
]}

Arita, Tsuyoshi ^{[1
]}

Hara, Takashi ^{[2
]}

Konishi, Masahiro ^{[2
]}

Abe-Ohya, Rie ^{[2
]}

Izumi, Masanori ^{[2
]}

Sogawa, Yoshitaka ^{[2
]}

Nagai, Yoko ^{[3
]}

Yoshida, Kazuhiro ^{[3
]}

Abe, Yasuyuki ^{[4
]}

Kimura, Takako ^{[5
]}

Takahashi, Hisashi ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[3] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[4] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan

[5] Daiichi Sankyo RD NOVARE Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2015年 / 23卷 / 01期

关键词：

Anti-obesity; Antedrug; Bombesin receptor subtype-3 (BRS-3); Brain penetration; Diazepine; TERT-BUTANESULFINYL IMINES; ASYMMETRIC-SYNTHESIS; BODY-TEMPERATURE; NERVOUS-SYSTEM; OBESE SUBJECTS; WEIGHT-LOSS; DISCOVERY; OVERWEIGHT; AMINES; SIBUTRAMINE;

D O I：

10.1016/j.bmc.2014.11.018

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Novel compounds based on the lead BRS-3 agonists from our HTS compounds 2a and 2b have been synthesized with the focus on obtaining peripheral BRS-3 agonists. To identify potent anti-obesity compounds without adverse effects on the central nerve system, a labile carboxylic ester with an antedrug functionality was introduced onto the terminal position. Through the extensive synthetic exploration and the pharmacokinetic studies of oral administration in mice, the phenol ester 17c was selected due to the most suitable pharmacological profile. In the evaluation of food intake suppression in B6 mice, 17c showed significant in vivo efficacy and no clear adverse effect on heart rate and blood pressure change in dog iv infusion. Our study paved the way for development of anti-diabetes and obesity drugs with a safer profile. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：89 / 104

页数：16

共 50 条

[1] BRS-3 (Bombesin Receptor Subtype-3) agonists for the treatment of obesity
Reitman, Marc
JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 : S179 - S179
[2] Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration
Matsufuji, Tetsuyoshi
Shimada, Kousei
Kobayashi, Shozo
Kawamura, Asuka
Fujimoto, Teppei
Arita, Tsuyoshi
Hara, Takashi
Konishi, Masahiro
Abe-Ohya, Rie
Izumi, Masanori
Sogawa, Yoshitaka
Nagai, Youko
Yoshida, Kazuhiro
Takahashi, Hisashi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 750 - 755
[3] Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists
Lo, Michael M. -C.
Chobanian, Harry R.
Palyha, Oksana
Kan, Yanqing
Kelly, Theresa M.
Guan, Xiao-Ming
Reitman, Marc L.
Dragovic, Jasminka
Lyons, Kathryn A.
Nargund, Ravi P.
Lin, Linus S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 2040 - 2043
[4] Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists
Kiyotsuka, Yohei
Shimada, Kousei
Kobayashi, Shozo
Suzuki, Masanori
Akiu, Mayuko
Asano, Masayoshi
Sogawa, Yoshitaka
Hara, Takashi
Konishi, Masahiro
Abe-Ohya, Rie
Izumi, Masanori
Nagai, Yoko
Yoshida, Kazuhiro
Abe, Yasuyuki
Takamori, Hideo
Takahashi, Hisashi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4205 - 4210
[5] Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity
Liu, Jian
He, Shuwen
Jian, Tianying
Dobbelaar, Peter H.
Sebhat, Iyassu K.
Lin, Linus S.
Goodman, Allan
Guo, Cheng
Guzzo, Peter R.
Hadden, Mark
Henderson, Alan J.
Pattamana, Kevin
Ruenz, Megan
Sargent, Bruce J.
Swenson, Brian
Yet, Larry
Tamvakopoulos, Constantin
Peng, Qianping
Pan, Jie
Kan, Yanqing
Palyha, Oksana
Kelly, Theresa M.
Guan, Xiao-Ming
Howard, Andrew D.
Marsh, Donald J.
Metzger, Joseph M.
Reitman, Marc L.
Wyvratt, Matthew J.
Nargund, Ravi P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2074 - 2077
[6] Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes
Ramos-Alvarez, Irene
Martin-Duce, Antonio
Moreno-Villegas, Zaida
Sanz, Raul
Aparicio, Cesar
Portal-Nunez, Sergio
Mantey, Samuel A.
Jensen, Robert T.
Gonzalez, Nieves
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 367 (1-2) : 109 - 115
[7] Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3)
Liu, J
Lao, ZJ
Zhang, JP
Schaeffer, MT
Jiang, MM
Guan, XM
Van der Ploeg, LHT
Fong, TM
BIOCHEMISTRY, 2002, 41 (28) : 8954 - 8960
[8] Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity
Hadden, Mark
Goodman, Allan
Guo, Cheng
Guzzo, Peter R.
Henderson, Alan J.
Pattamana, Kevin
Ruenz, Megan
Sargent, Bruce J.
Swenson, Brian
Yet, Larry
Liu, Jian
He, Shuwen
Sebhat, Iyassu K.
Lin, Linus S.
Tamvakopoulos, Constantin
Peng, Qianping
Kan, Yanqing
Palyha, Oksana
Kelly, Theresa M.
Guan, Xiao-Ming
Metzger, Joseph M.
Reitman, Marc L.
Nargund, Ravi P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2912 - 2915
[9] Chiral Diazepines Analogs Are Selective, Potent Agonists for the Orphan Bombesin Receptor, BRS-3
Ramos, Irene
Nakamura, Taichi
Mantey, Samuel A.
Jensen, Robert T.
GASTROENTEROLOGY, 2015, 148 (04) : S733 - S734
[10] Pharmacokinetics and Pharmacodynamics of MK-5046, a Bombesin Receptor Subtype-3 (BRS-3) Agonist, in Healthy Patients
Reitman, Marc L.
Dishy, Victor
Moreau, Allison
Denney, William S.
Liu, Chengcheng
Kraft, Walter K.
Mejia, Alex V.
Matson, Mark A.
Stoch, S. Aubrey
Wagner, John A.
Lai, Eseng
JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (09): : 1306 - 1316

← 1 2 3 4 5 →